Skip to main content
Log in

Wie gefährlich ist die Hormonersatztherapie (HRT) in der Menopause?

  • Kommentar
  • Published:
Wiener Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 363: 419–427

    Google Scholar 

  2. Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288: 321–333

    Article  Google Scholar 

  3. Grodstein F, et al. (1997) Postmenopausal hormone therapy and mortality. N Engl J Med 336: 1769–1776.

    Article  PubMed  CAS  Google Scholar 

  4. Gruber Ch, Tschugguel W, Schneeberger Ch, Huber JC (2002) Production and action of estrogens. N Engl J Med 346: 340–352.

    Article  PubMed  CAS  Google Scholar 

  5. Gruber DM, Sator MO, Huber JC (1997) Hormone replacement therapy and breast cancer. Lancet 350: 1628

    Article  PubMed  CAS  Google Scholar 

  6. HABITS (hormonal replacement therapy after breast cancer — is it safe?), a randomised comparison: trial stopped. Lancet 363 (9407): 453–455 (2004)

    Article  Google Scholar 

  7. Phytoöstrogene — eine Alternative zur HRT. Ärztezeitung (2004)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johannes C. Huber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huber, J.C. Wie gefährlich ist die Hormonersatztherapie (HRT) in der Menopause?. Wien Klin Wochenschr 116, 155–158 (2004). https://doi.org/10.1007/BF03040481

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03040481

Key words

Navigation